Literature DB >> 8154032

The impact of an acute rejection episode on long-term renal allograft survival (t1/2).

A J Matas1, K J Gillingham, W D Payne, J S Najarian.   

Abstract

An acute renal transplant rejection episode has been shown to be associated with decreased 1-year graft survival. The impact on long-term outcome is undefined. We studied the impact of an acute rejection episode on t1/2, the time it takes for 1/2 of the grafts functioning at 1 year to fail. Use of t1/2 avoids inclusion of early graft loss to acute rejection or complications of treatment. Since 1/1/86, a total of 653 patients have received a primary kidney transplant and had at least 1 year of function. Recipients were divided by the incidence and timing of rejection: no rejection; 1 rejection within the first year; > 1 rejection, the first episode in the first year; and > or = 1 rejection, the first episode after the first year. A single rejection episode in the first year reduced t1/2 (45 +/- 11 years in those with no rejection vs. 25 +/- 8 years in those with 1 in the first year). Multiple rejections (t1/2 = 5 +/- 11 years) and a first rejection after the first year (t1/2 = 3 +/- 1 years) have a significant effect (P < .05). Both living and cadaver donor recipients with rejection had shortened t1/2. For those with > 1 rejection, the first episode in the first year, and those with > or = 1 rejection, the first episode after the first year, chronic rejection was the predominant cause of graft loss; noncompliance also played a role. We conclude that a single rejection episode shortens t1/2. Those with > 1 rejection, the first episode within the first year, and those with > or = 1 rejection, the first episode after the first year, are at high risk for late graft loss.

Entities:  

Mesh:

Year:  1994        PMID: 8154032     DOI: 10.1097/00007890-199403270-00015

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  51 in total

1.  Neutrophils mediate parenchymal tissue necrosis and accelerate the rejection of complete major histocompatibility complex-disparate cardiac allografts in the absence of interferon-gamma.

Authors:  Masayoshi Miura; Tarek El-Sawy; Robert L Fairchild
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

2.  Early T cell response to allografts occurring prior to alloantigen priming up-regulates innate-mediated inflammation and graft necrosis.

Authors:  Tarek El-Sawy; Masayoshi Miura; Robert Fairchild
Journal:  Am J Pathol       Date:  2004-07       Impact factor: 4.307

3.  Neutralizing IL-6 reduces human arterial allograft rejection by allowing emergence of CD161+ CD4+ regulatory T cells.

Authors:  Birgit Fogal; Tai Yi; Chen Wang; Deepak A Rao; Amir Lebastchi; Sanjay Kulkarni; George Tellides; Jordan S Pober
Journal:  J Immunol       Date:  2011-11-14       Impact factor: 5.422

4.  Periodontitis case definition affects the association with renal function in kidney transplant recipients.

Authors:  E Ioannidou; M Shaqman; J Burleson; A Dongari-Bagtzoglou
Journal:  Oral Dis       Date:  2010-10       Impact factor: 3.511

5.  Validation of single nucleotide polymorphisms associated with acute rejection in kidney transplant recipients using a large multi-center cohort.

Authors:  William S Oetting; David P Schladt; Robert E Leduc; Pamala A Jacobson; Weihua Guan; Arthur J Matas; Ajay Israni
Journal:  Transpl Int       Date:  2011-09-29       Impact factor: 3.782

6.  Donor P-gp polymorphisms strongly influence renal function and graft loss in a cohort of renal transplant recipients on cyclosporine therapy in a long-term follow-up.

Authors:  J-B Woillard; J-P Rerolle; N Picard; A Rousseau; A Guillaudeau; E Munteanu; M Essig; M Drouet; Y Le Meur; P Marquet
Journal:  Clin Pharmacol Ther       Date:  2010-05-26       Impact factor: 6.875

7.  Ten-year outcome after rapid discontinuation of prednisone in adult primary kidney transplantation.

Authors:  Michael D Rizzari; Thomas M Suszynski; Kristen J Gillingham; Ty B Dunn; Hassan N Ibrahim; William D Payne; Srinath Chinnakotla; Erik B Finger; David E R Sutherland; Raja Kandaswamy; John S Najarian; Timothy L Pruett; Aleksandra Kukla; Richard Spong; Arthur J Matas
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 8.237

8.  Analysis of 75 Candidate SNPs Associated With Acute Rejection in Kidney Transplant Recipients: Validation of rs2910164 in MicroRNA MIR146A.

Authors:  William S Oetting; David P Schladt; Casey R Dorr; Baolin Wu; Weihua Guan; Rory P Remmel; David Iklé; Roslyn B Mannon; Arthur J Matas; Ajay K Israni; Pamala A Jacobson
Journal:  Transplantation       Date:  2019-08       Impact factor: 4.939

Review 9.  Anti-interleukin-2 receptor antibodies for the prevention of rejection in pediatric renal transplant patients: current status.

Authors:  Agnieszka Swiatecka-Urban
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

10.  The value of serum neopterin, interferon-gamma levels and interleukin-12B polymorphisms in predicting acute renal allograft rejection.

Authors:  G K Chin; C L Adams; B S Carey; S Shaw; W-Y Tse; E R Kaminski
Journal:  Clin Exp Immunol       Date:  2008-03-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.